| |
|
|
|
Xtalks, Online
2024-11-14
Claims and structured electronic health record (EHR) data are tried-and-true real-world data (RWD) sources — life sciences researchers have trusted these data for years, answering questions from pre-clinical to post-launch.
But, what if more information is required, beyond what is typically captured in structured claims and EHR data? What if additional details are required about disease progression, lifestyle behaviors or treatment response that do not fit neatly into traditional data fields? Multi-modal data sources can provide this more granular, high-value patient data.
With increasingly competitive therapeutic markets, shifting payer priorities and complex patient subpopulations, the evidence generation stakes are higher than ever. The use of enriched clinical data, unstructured clinical notes and genomic data presents opportunities to analyze and fully understand the patient journey from a different lens.
In this webinar, the expert speakers will have an in-depth conversation on applications and use cases for these multi-modal data, including how to determine the fit-for-purpose nature of a data set and ways that these data can help organizations continue innovating and helping patients in a dynamic, evolving market.
Register for this webinar today to explore how multi-modal data sources can provide insights into patient journeys and enhance evidence generation.
Keywords: Clinical Research, Real-World Data, Real-World Evidence, Clinical Data, HEOR, RWE, Data Science, Multimodal Data, Commercialization/HEOR/Market Access, RWD
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Lou Brooks, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences
Erin Hulbert, Director, Value-Based Contracting and Services, Optum Life Sciences
Danita Kiser, Vice President, Innovation and Strategy, UnitedHealth Group
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-11-14
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|